Ranjan, Sivaja
Young, David
Sun, Fangshi
Article History
Received: 12 February 2018
Accepted: 1 June 2018
First Online: 3 July 2018
Ethics approval
: The protocol was reviewed and approved by the local Institutional Animal Care and Use Committee. The study was conducted in accordance with the most recent versions of FDA/CVM Good Clinical Practice Guidance #85, May 9, 2001; VICH GL9 “Good Clinical Practice” (GCP) adopted by CVMP in June 2000 (CVMP/VICH/595/98-Final); EMEA Guideline for the Testing and Evaluation of the Efficacy of Antiparasitic Substances for the Treatment and Prevention of Tick and Flea Infestation in Dogs and Cats. EMEA/CVMP/EWP/005/2000, 12 November 2007.
: The study was funded by Merck Animal Health, 2 Giralda Farm, Madison, NJ, USA. SR and FS are current employees of MAH, DY is a current employee of Young Veterinary Research Services and was contracted by MAH to conduct the studies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.